Bnp |verified| — Test
BNP elevated at 850 pg/mL (normal <100). This finding is consistent with acute decompensated heart failure in the appropriate clinical context. Renal function (Cr 1.2) does not explain the elevation.
Patient with acute shortness of breath │ ├── BNP < 100 pg/mL (or NT-proBNP < 300) │ → Heart failure very unlikely │ → Investigate pulmonary, infectious, or other cardiac causes │ ├── BNP 100–400 pg/mL │ → Gray zone │ → Consider: obesity, HFpEF, PE, moderate renal disease │ → Order echocardiogram +/- serial BNP │ └── BNP > 400 pg/mL (or NT-proBNP > 1200 acute) → Heart failure highly likely → Start diuresis/vasodilators; obtain echo for EF assessment test bnp
After a heart attack (acute coronary syndrome), elevated BNP levels can predict long-term risks of mortality or future cardiac events. BNP elevated at 850 pg/mL (normal <100)
Results are typically measured in picograms per milliliter (pg/mL). Generally, lower levels are better, and higher levels indicate greater heart stress. Patient with acute shortness of breath │ ├──
NT-proBNP (N-terminal pro b-type natriuretic peptide) is an inactive fragment co-secreted with BNP. It has a longer half-life and is often used interchangeably but with different reference ranges.
As a highly effective, non-invasive diagnostic tool, the BNP test helps clinicians distinguish between heart failure and other causes of breathing difficulties (dyspnea), making it indispensable in emergency departments and cardiology clinics. What Does the BNP Test Measure?